
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
---|---|---|---|---|---|---|
09/30/2025 | Q3 | $2.7M | -- | -- | -$0.71 | -- |
08/01/2025 | Q2 | $2.7M | -- | -- | -$0.72 | -- |
05/07/2025 | Q1 | $8.6M | $1.8M | -$0.88 | -$0.84 | -$0.04 |
02/26/2025 | Q4 | $8.1M | $11.3M | -$0.76 | -$0.87 | $0.11 |
10/31/2024 | Q3 | $5.5M | $289K | -$1.56 | -$1.08 | -$0.48 |
08/01/2024 | Q2 | $7.5M | $941K | -$1.02 | -$0.89 | -$0.13 |
05/02/2024 | Q1 | $11.7M | $51.2M | -$0.48 | -$1.05 | $0.57 |
02/22/2024 | Q4 | $11.2M | $9.6M | -$0.86 | -$1.00 | $0.14 |
11/02/2023 | Q3 | -- | -- | -$1.22 | -$1.19 | -$0.03 |
08/03/2023 | Q2 | -- | -- | -$1.45 | -$1.19 | -$0.26 |
05/04/2023 | Q1 | -- | -- | -$1.06 | -$0.86 | -$0.20 |
02/23/2023 | Q4 | -- | -- | -$0.76 | -$0.42 | -$0.34 |
11/03/2022 | Q3 | -- | -- | $1.30 | -$0.31 | $1.61 |
08/04/2022 | Q2 | -- | -- | -$0.58 | $0.46 | -$1.04 |
05/05/2022 | Q1 | -- | -- | $3.85 | $3.62 | $0.24 |
02/24/2022 | Q4 | -- | -- | $3.92 | $1.56 | $2.36 |
11/04/2021 | Q3 | -- | -- | $0.82 | $0.09 | $0.73 |
08/05/2021 | Q2 | -- | -- | $0.46 | -$0.40 | $0.86 |
05/06/2021 | Q1 | -- | -- | -$1.32 | -$0.11 | -$1.21 |
02/25/2021 | Q4 | -- | -- | -$0.83 | -$0.70 | -$0.13 |
11/10/2020 | Q3 | -- | -- | -$0.67 | -$0.60 | -$0.07 |
08/11/2020 | Q2 | -- | -- | -$0.27 | -$0.62 | $0.35 |
05/12/2020 | Q1 | -- | -- | -$0.71 | -$0.56 | -$0.15 |
03/26/2020 | Q4 | -- | -- | -$0.71 | -$0.63 | -$0.08 |
11/19/2019 | Q3 | -- | -- | -$0.44 | -$3.34 | $2.89 |
Vir Biotechnology reported $1.8M worth of top line sales in its most recent quarter.
Vir Biotechnology announced earnings per share of -$0.88 which represents a miss of analyst forecast a -$0.84 per share.
Vir Biotechnology reported $1.8M that represents $0.01 per share over the last quarter.
Vir Biotechnology's earnings are forecast to decrease from -$3.83 per share to -$3.92 per share next year representing a decrease of -16.69%.
Vir Biotechnology's next earnings date is August 1, 2025.
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.